Physician

Mehdi Najafi, M.D.,PH.D.

According to 2025 Medicare claims, Mehdi Najafi, M.D., PH.D. (NPI: 1003252297) practices ophthalmology in the Boston, MA market, with the plurality of this provider's patient population coming from Norfolk, MA. This provider's primary affiliated billing organization is NORWOOD EYE CARE SPECIALISTS, LLC (NPI: 1942965421; TIN: 872113040) and primary practice location at 02062-3488. Najafi is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490), participating under the MSSP model.

Najafi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,004 traditional Medicare patients, billed 18,366 HCPCS/CPT codes, and received $1,515,200 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 357 prescription claims across 126 beneficiaries totaling $14,285 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 4 records totaling $164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,352 to $1,515,200. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,745 to $14,285. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$911K$1.8M2017 Medicare payment: $3,352 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $8,309 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $428,684 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,023,342 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,418,818 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,635,299 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,822,583 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,515,200 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20172034$3,352
20186098$8,309
20196122,456$428,684
20208125,134$1,023,342
20211,0166,693$1,418,818
20221,2367,905$1,635,299
20231,34016,090$1,822,583
20241,00418,366$1,515,200

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$28K2015 Drug cost: $3,745 (USD; Tot_Drug_Cst)2016 Drug cost: $8,041 (USD; Tot_Drug_Cst)2017 Drug cost: $6,682 (USD; Tot_Drug_Cst)2018 Drug cost: $12,278 (USD; Tot_Drug_Cst)2019 Drug cost: $17,325 (USD; Tot_Drug_Cst)2020 Drug cost: $28,230 (USD; Tot_Drug_Cst)2021 Drug cost: $26,036 (USD; Tot_Drug_Cst)2022 Drug cost: $23,449 (USD; Tot_Drug_Cst)2023 Drug cost: $25,194 (USD; Tot_Drug_Cst)2024 Drug cost: $14,285 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152760$3,745
201653182$8,041
201747126$6,682
201898262$12,278
201987211$17,325
2020106414$28,230
2021126483$26,036
2022113435$23,449
2023127507$25,194
2024126357$14,285

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1431,092$658
67028Injection of drug into eye2951,083$99
92014Established patient complete exam of visual system9371,397$92
J9035Injection, bevacizumab, 10 mg119406$55
92134Imaging of retina9742,046$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1206,047$5,325
Ketorolac TromethamineKetorolac Tromethamine843,854$1,780
Brimonidine TartrateBrimonidine Tartrate11630$1,449
OfloxacinOfloxacin41885$414
LatanoprostLatanoprost261,712$250

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$164Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mehdi Najafi, M.D., PH.D.?

Tedicare shows public-source Medicare data for Mehdi Najafi, M.D., PH.D. (NPI 1003252297), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mehdi Najafi, M.D., PH.D. have ACO affiliation data?

Mehdi Najafi, M.D., PH.D. is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490).

What billing organization is linked to Mehdi Najafi, M.D., PH.D.?

Mehdi Najafi, M.D., PH.D. is linked to NORWOOD EYE CARE SPECIALISTS, LLC (billing NPI 1942965421) in the available physician profile data.

Does Mehdi Najafi, M.D., PH.D. have Open Payments data?

Mehdi Najafi, M.D., PH.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.